Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-04
1993-06-29
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514280, 514285, 546 41, 546 48, 546 61, A61K 3144, C07D47100
Patent
active
052235068
ABSTRACT:
The present invention relates to certain substituted tetracyclic fused quinoline derivatives of formula (I): ##STR1## wherein: R.sup.1 is hydrogen, hydroxy, fluoro, chloro, bromo, iodo, methoxy or amino;
REFERENCES:
patent: 3647801 (1972-03-01), Petrzilka
Tetrahedron, 29, 359-362 (1973).
J. Ind. Chem. Soc., 7, 638-645.
Synthesis, 6, 458-561 (1989).
Chem. Abstracts, 112, No. 7, (1990).
Tetrahedron, 46, 2445-2452 (1990).
J. Med. Chem., 14, 1116-1118 (1971).
J. Heterocyclic Chem., 10, 1035-1038 (1973).
J. Med. Chem., 33, 972-978 (1990).
A. Lehninger, Principles of Biochemistry, 813, Worth Publishers, New York, 1982.
F. Liu, DNA Topoisomerases, CRC Critical Review in Biochemistry, 1-24, 15 1983.
H. Vosberg, DNA Topoisomerases: Enzymes that control Conformation, Current Topics in Microbiology and Immunology 19, 1985.
E. Nelson, et al., Proc. Nat. Acad Sci., USA, 81, 1361 1984.
C. Chang, "Friedlander Synthesis of Quinolines", Organic reactiond, 28, 37-201, John Wiley, New York 1982 pp. 92-99 vol. 28.
T. Green, Protective Group in Organic Chemistry Chap 3 John Wiley, New York 1981.
A. I. Vogel, Practical Organic Chemistry, 4th Ed., 773 Longmans, London 1978.
Y. Hsiang, et al., J. Biol. Chem., 260:14873-14878 1985.
Y. Hsiang, et al., Cancer research, 49:4385-4389 1989.
Jaxel, et al Cancer Research, 49:1465-1469.
DNA Topoisomerase in Cancer, M. Potmesil, et al., Ed's., Oxford University Press (1991).
Besterman Jeffrey M.
Dezube Milana
Evans Michael G.
Johnson M. Ross
Luzzio Michael J.
Cintins Marianne M.
Glaxo Inc.
Joyner Charles T.
Kilby Scalzo Catherine S.
LandOfFree
Cyclic antitumor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclic antitumor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclic antitumor compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1755628